Related Experiment Video

Updated: Aug 19, 2026

DNA Vector-based RNA Interference to Study Gene Function in Cancer
13:10

DNA Vector-based RNA Interference to Study Gene Function in Cancer

Published on: June 4, 2012

RNAi technology and lentiviral delivery as a powerful tool to suppress Tpr-Met-mediated tumorigenesis

Riccardo Taulli1, Paolo Accornero, Antonia Follenzi

  • 1Center for Experimental Research and Medical Studies (CERMS), Molinette Hospital, Turin, Italy.

Cancer Gene Therapy
|February 19, 2005
PubMed

Insights

Short interfering RNA (siRNA) targeting the Tpr-Met oncogene effectively suppressed its expression and Tpr-Met-driven cancer development. Lentiviral delivery of this siRNA shows promise for treating Tpr-Met-positive gastric cancers.

Area of Science:

  • Oncology
  • Molecular Biology
  • RNA Interference

Background:

  • The Tpr-Met oncogene, a variant of the Met receptor, is present in gastric cancers and precursor lesions.
  • Its presence suggests a role in gastric tumor development.
  • RNA interference offers a way to target specific oncogenes like Tpr-Met.

Purpose of the Study:

  • To investigate the potential of targeting Tpr-Met using short interfering RNA (siRNA).
  • To assess the efficacy of an anti-Tpr-Met siRNA in inhibiting Tpr-Met-mediated transformation and tumorigenesis.

Main Methods:

  • Development of a specific short interfering RNA (siRNA) targeting the Tpr-Met junction (anti-TM2).
  • Delivery of anti-TM2 siRNA using a lentiviral vector.
  • Testing efficacy in mouse embryonal fibroblasts and epithelial cells with high Tpr-Met expression.

Main Results:

  • Specific suppression of Tpr-Met expression was achieved by anti-TM2 siRNA.
  • Inhibition of Tpr-Met-mediated transformation and tumorigenesis was observed.
  • Lentiviral delivery of anti-TM2 siRNA demonstrated effectiveness in relevant cell models.

Conclusions:

  • Anti-TM2 siRNA specifically targets and suppresses Tpr-Met.
  • Lentiviral-mediated delivery of anti-TM2 siRNA is a potential therapeutic strategy.
  • This approach could be developed for treating Tpr-Met-positive cancers.

More Related Videos

Dual CRISPR-Interference Strategy for Targeting Synthetic Lethal Interactions Between Non-Coding RNAs in Cancer Cells07:23

Dual CRISPR-Interference Strategy for Targeting Synthetic Lethal Interactions Between Non-Coding RNAs in Cancer Cells

Published on: May 30, 2025

In vivo Application of the REMOTE-control System for the Manipulation of Endogenous Gene Expression08:54

In vivo Application of the REMOTE-control System for the Manipulation of Endogenous Gene Expression

Published on: March 29, 2019

Related Concept Videos

Experimental RNAi02:15

Experimental RNAi

RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
piRNA - Piwi-interacting RNAs02:57

piRNA - Piwi-interacting RNAs

PIWI-interacting RNAs, or piRNAs, are the most abundant short non-coding RNAs. More than 20,000 genes have been found in humans that code for piRNAs while only 2000 genes have been found for miRNAs. piRNAs can act at the transcriptional and post-transcriptional levels and have a vital role in silencing transposable elements present in germ cells. They are also involved in epigenetic silencing and activation. Previously, they were thought to function only in germ cells but new evidence suggests...
Non-LTR Retrotransposons03:18

Non-LTR Retrotransposons

As the name suggests, non-LTR retrotransposons lack the long terminal repeats characteristic of the LTR retrotransposons. Additionally, both LTR and non-LTR retrotransposons use distinct mechanisms of mobilization. Non-LTR retrotransposons are further divided into two classes - Long interspersed nuclear elements (LINEs) and short interspersed nuclear elements (SINEs), both of which occur abundantly in most mammals, including humans. Some of the active non-LTR retrotransposons in humans are L1...
RNA Interference01:23

RNA Interference

RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
RNA Interference01:23

RNA Interference

RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
siRNA - Small Interfering RNAs02:30

siRNA - Small Interfering RNAs

Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the ATP-dependent...